新闻报导

What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?

Explore the top challenges in cell & gene therapy commercialization, featuring expert insights from Fran…

Certara2025 年 9 月 12 日

Guide

Top 10 Things to Know About ADNCA for Non-Compartmental Analysis

Learn how to transition from non-standard ADPC datasets to the CDISC ADNCA ADaM standard. Improve…

Certara2025 年 9 月 11 日

On-Demand Webinar

TrialAssure & Certara Joint Webinar: Authoring Clinical Documents with Downstream Regulatory Requirements in Mind

Watch our on-demand webinar from Certara and TrialAssure to learn how to author clinical documents…

Certara2025 年 9 月 10 日

Press Coverage

Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research

The article, "Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research," explores a…

Danielle Pillsbury2025 年 9 月 10 日

Press Coverage

AI-driven drug discovery picks up as FDA pushes to reduce animal testing

AI is revolutionizing drug discovery and safety testing as drug developers adopt these technologies in…

Certara2025 年 9 月 9 日

Conference

Redefining Every Stage of Investment (RESI) Seed to Exit

–

Certara2025 年 9 月 5 日

Case Study

Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise

Learn how Certara's project management team helped a large biotech streamline the development and updates…

Certara2025 年 9 月 5 日

Blog

Clinical trials regulation (EU) no. 536/2014 – The impact on annual safety reporting

Stay compliant with EU rules for the pharmaceutical industry. Learn about annual safety reports and…

Certara2025 年 9 月 5 日

Live Events

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

– London, UK

Certara2025 年 9 月 4 日

On-Demand Webinar

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

Watch leading experts from Pfizer, Merck, Amicus, and Certara discuss how Integrated Evidence can bridge…

Certara2025 年 9 月 3 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

Certara 服务

What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?

Top 10 Things to Know About ADNCA for Non-Compartmental Analysis

TrialAssure & Certara Joint Webinar: Authoring Clinical Documents with Downstream Regulatory Requirements in Mind

Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research

AI-driven drug discovery picks up as FDA pushes to reduce animal testing

Redefining Every Stage of Investment (RESI) Seed to Exit

Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise

Clinical trials regulation (EU) no. 536/2014 – The impact on annual safety reporting

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

订阅时事通讯

快捷链接

解决方案

联系我们